Alnylam Pharmaceuticals
ALNY
ALNY
254 hedge funds and large institutions have $4.42B invested in Alnylam Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 113 increasing their positions, 63 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 260 → 254 (-6)
29% less capital invested
Capital invested by funds: $6.22B → $4.42B (-$1.8B)
Holders
254
Holding in Top 10
9
Calls
$56.3M
Puts
$50.9M
Top Buyers
| 1 | +$80.9M | |
| 2 | +$43.4M | |
| 3 | +$40.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$34.5M |
| 5 |
SPC
Slate Path Capital
New York
|
+$25.7M |
Top Sellers
| 1 | -$47.9M | |
| 2 | -$32.6M | |
| 3 | -$16.9M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$16.8M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$13.4M |